Authors: Wu, HY Reding, M Qian, J Okita, DK Parker, E Lollar, P Hoyer, LW Conti-Fine, BM

Citation: Hy. Wu et al., Mechanism of the immune response to human factor VIII in murine hemophiliaA, THROMB HAEM, 85(1), 2001, pp. 125-133

Authors: Scandella, DH Nakai, H Felch, M Mondorf, W Scharrer, I Hoyer, LW Saenko, EL

Citation: Dh. Scandella et al., In hemophilia A and autoantibody inhibitor patients: The factor VIII A2 domain and light chain are most immunogenic, THROMB RES, 101(5), 2001, pp. 377-385

Authors: Qian, JH Burkly, LC Smith, EP Ferrant, JL Hoyer, LW Scott, DW Haudenschild, CC

Citation: Jh. Qian et al., Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer, EUR J IMMUN, 30(9), 2000, pp. 2548-2554

Authors: Qian, JH Collins, M Sharpe, AH Hoyer, LW

Citation: Jh. Qian et al., Prevention and treatment of factor VIII inhibitors in murine hemophilia A, BLOOD, 95(4), 2000, pp. 1324-1329

Authors: Hoyer, LW

Citation: Lw. Hoyer, 1999 State of the Art - Preface, THROMB HAEM, 82(2), 1999, pp. I-I

Authors: Qian, JJ Borovok, M Bi, L Kazazian, HH Hoyer, LW

Citation: Jj. Qian et al., Inhibitor antibody development and T cell response to human factor VIII inmurine hemophilia A, THROMB HAEM, 81(2), 1999, pp. 240-244